The Current Ratio as of November 2024 (TTM) for Diffusion Pharmaceuticals Inc. (DFFN) is 10.96

According to Diffusion Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.96. This represents a change of 10.43% compared to the average of 9.92 of the last 4 quarters.

Diffusion Pharmaceuticals Inc. (DFFN) Historical Current Ratio (quarterly & annually)

How has DFFN Current Ratio performed in the past?

The mean historical Current Ratio of Diffusion Pharmaceuticals Inc. over the last ten years is 7.43. The current 10.96 Current Ratio has changed 14.64% with respect to the historical average. Over the past ten years (40 quarters), DFFN's Current Ratio was at its highest in in the March 2021 quarter at 22.39. The Current Ratio was at its lowest in in the March 2014 quarter at 0.25.

Diffusion Pharmaceuticals Inc. (DFFN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Diffusion Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Diffusion Pharmaceuticals Inc. (DFFN) Average Current Ratio

How has DFFN Current Ratio performed in the past?

The current Current Ratio of Diffusion Pharmaceuticals Inc. (DFFN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Diffusion Pharmaceuticals Inc. (DFFN) Current Ratio vs. Peers

How is DFFN’s Current Ratio compared to its peers?

Diffusion Pharmaceuticals Inc.’s Current Ratio is greater than Bio-Path Holdings, Inc. (0.86), greater than Catalyst Biosciences, Inc. (0), greater than Capricor Therapeutics, Inc. (4.19), greater than NextCure, Inc. (9.07), greater than Tonix Pharmaceuticals Holding Corp. (3.33), greater than Jaguar Health, Inc. (1.84), greater than Acasti Pharma Inc. (7.86), greater than iBio, Inc. (3.37), less than Pulmatrix, Inc. (0), less than Akari Therapeutics, Plc (19.40), greater than Soleno Therapeutics, Inc. (0.29), less than Cellectar Biosciences, Inc. (17.26), greater than Monopar Therapeutics Inc. (1.77), less than Tenax Therapeutics, Inc. (5.41K), less than null (38.95),

Build a custom stock screener for Diffusion Pharmaceuticals Inc. (DFFN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diffusion Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Diffusion Pharmaceuticals Inc. (DFFN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Diffusion Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.